Literature DB >> 16144876

Differential amplification of murine bipotent megakaryocytic/erythroid progenitor and precursor cells during recovery from acute and chronic erythroid stress.

Massimo Sanchez1, Irving L Weissman, Maria Pallavicini, Mauro Valeri, Paola Guglielmelli, Alessandro Maria Vannucchi, Giovanni Migliaccio, Anna Rita Migliaccio.   

Abstract

Two murine bipotent erythroid/megakaryocytic cells, the progenitor (MEP) and precursor (PEM) cells, recently have been identified on the basis of the phenotypes of linnegc-kitposSca-1neg CD16/CD32lowCD34low and TER119pos4A5pos or 2D5pos, respectively. However, the functional relationship between these two subpopulations and their placement in the hemopoietic hierarchy is incompletely understood. We compared the biological properties of these subpopulations in marrow and spleen of mice with and without acute or chronic erythroid stress. MEP cells, but not PEM cells, express c-kit, respond to stem cell factor in vitro, and form spleen colonies in vivo. PEM cells comprise up to 50%-70% of the cells in BFU-E-derived colonies but are not present among the progeny of purified MEP cells cultured under erythroid and megakaryocytic permissive conditions. PEM cells increase 10- to 20-fold under acute and chronic stress, whereas MEP cell increases (21%-84%) are observed only in acutely stressed animals. These data suggest that MEP and PEM cells represent distinct cell populations that may exist in an upstream-downstream differentiation relationship under conditions of stress. Whereas the dynamics of both populations are altered by stress induction, the differential response to acute and chronic stress suggests different regulatory mechanisms. A model describing the relationship between MEP, PEM, and common myeloid progenitor cells is presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16144876     DOI: 10.1634/stemcells.2005-0023

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  11 in total

1.  The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor.

Authors:  Barbara Ghinassi; Massimo Sanchez; Fabrizio Martelli; Giovanni Amabile; Alessandro Maria Vannucchi; Giovanni Migliaccio; Stuart H Orkin; Anna Rita Migliaccio
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

Review 2.  GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.

Authors:  Te Ling; John D Crispino; Maria Zingariello; Fabrizio Martelli; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2018-02-19       Impact factor: 2.929

3.  Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation.

Authors:  Anna Rita Migliaccio; Fabrizio Martelli; Maria Verrucci; Massimo Sanchez; Mauro Valeri; Giovanni Migliaccio; Alessandro Maria Vannucchi; Maria Zingariello; Angela Di Baldassarre; Barbara Ghinassi; Rosa Alba Rana; Yvette van Hensbergen; Willem E Fibbe
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113

4.  H3 K79 dimethylation marks developmental activation of the beta-globin gene but is reduced upon LCR-mediated high-level transcription.

Authors:  Tomoyuki Sawado; Jessica Halow; Hogune Im; Tobias Ragoczy; Emery H Bresnick; M A Bender; Mark Groudine
Journal:  Blood       Date:  2008-04-25       Impact factor: 22.113

5.  A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor.

Authors:  Eyayu Belay; Chris P Miller; Amanda N Kortum; Beverly Torok-Storb; C Anthony Blau; David W Emery
Journal:  Blood       Date:  2014-10-24       Impact factor: 22.113

6.  Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.

Authors:  Anna Rita Migliaccio; Fabrizio Martelli; Maria Verrucci; Giovanni Migliaccio; Alessandro Maria Vannucchi; Hongyu Ni; Mingjiang Xu; Yi Jiang; Betty Nakamoto; Thalia Papayannopoulou; Ronald Hoffman
Journal:  Exp Hematol       Date:  2008-02       Impact factor: 3.084

7.  Thrombopoietin inhibits murine mast cell differentiation.

Authors:  Fabrizio Martelli; Barbara Ghinassi; Rodolfo Lorenzini; Alessandro M Vannucchi; Rosa Alba Rana; Mitsuo Nishikawa; Sandra Partamian; Giovanni Migliaccio; Anna Rita Migliaccio
Journal:  Stem Cells       Date:  2008-02-14       Impact factor: 6.277

Review 8.  Novel targets to cure primary myelofibrosis from studies on Gata1low mice.

Authors:  Maria Zingariello; Fabrizio Martelli; Paola Verachi; Claudio Bardelli; Francesca Gobbo; Maria Mazzarini; Anna Rita Migliaccio
Journal:  IUBMB Life       Date:  2019-11-21       Impact factor: 3.885

Review 9.  Evolving insights into the synergy between erythropoietin and thrombopoietin and the bipotent erythroid/megakaryocytic progenitor cell.

Authors:  Thalia Papayannopoulou; Kenneth Kaushansky
Journal:  Exp Hematol       Date:  2016-01-08       Impact factor: 3.084

10.  Removal of the spleen in mice alters the cytokine expression profile of the marrow micro-environment and increases bone formation.

Authors:  Fabrizio Martelli; Maria Verrucci; Giovanni Migliaccio; Maria Zingariello; Rosa Alba Rana; Alessandro Maria Vannucchi; Anna Rita Migliaccio
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.